These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23055868)

  • 1. Aminophylline compatibility with neonatal total parenteral nutrition.
    Sykes R; McPherson C; Foulks K; Wade J; Gal P
    J Pediatr Pharmacol Ther; 2008 Apr; 13(2):76-9. PubMed ID: 23055868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of retrograde aminophylline administration on calcium and phosphate solubility in neonatal total parenteral nutrient solutions.
    Kirkpatrick AE; Holcombe BJ; Sawyer WT
    Am J Hosp Pharm; 1989 Dec; 46(12):2496-500. PubMed ID: 2513716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing TrophAmine.
    Fitzgerald KA; MacKay MW
    Am J Hosp Pharm; 1986 Jan; 43(1):88-93. PubMed ID: 3082196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
    Fox LM; Wilder AG; Foushee JA
    Am J Health Syst Pharm; 2013 Mar; 70(6):520-4. PubMed ID: 23456406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual compatibility of 30 additives with a parenteral nutrient solution.
    Athanikar N; Boyer B; Deamer R; Harbison H; Henry RS; Jurgens R; Mett C; Sturgeon R; VanLeuven M; Welco A
    Am J Hosp Pharm; 1979 Apr; 36(4):511-3. PubMed ID: 107797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical stability of an all-in-one parenteral nutrition admixture for preterm infants upon mixing with micronutrients and drugs.
    Staven V; Wang S; Grønlie I; Tho I
    Eur J Hosp Pharm; 2020 Jan; 27(1):36-42. PubMed ID: 32064087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing Aminosyn PF.
    Fitzgerald KA; MacKay MW
    Am J Hosp Pharm; 1987 Jun; 44(6):1396-400. PubMed ID: 3113238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents.
    Staven V; Iqbal H; Wang S; Grønlie I; Tho I
    J Pharm Pharmacol; 2017 Apr; 69(4):448-462. PubMed ID: 27714809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical Compatibility of Amiodarone with Parenteral Nutrition.
    Mediavilla MM; Molina A; Navarro L; Grau L; Pujol MD; Cardenete J; Cardona D; Riera P
    JPEN J Parenter Enteral Nutr; 2019 Feb; 43(2):298-304. PubMed ID: 29992576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of shielding parenteral nutrition from light on routine monitoring of blood glucose and triglyceride levels in preterm neonates.
    Khashu M; Harrison A; Lalari V; Lavoie JC; Chessex P
    Arch Dis Child Fetal Neonatal Ed; 2009 Mar; 94(2):F111-5. PubMed ID: 18650223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of aminophylline and verapamil in intravenous admixtures.
    Johnson CE; Lloyd CW; Mesaros JL; Rubley GJ
    Am J Hosp Pharm; 1989 Jan; 46(1):97-100. PubMed ID: 2712035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free oxygen radical-induced lipid peroxidation and antioxidant in infants receiving total parenteral nutrition.
    Hasanoğlu A; Dalgiç N; Tümer L; Atalay Y; Cinasal G; Biberoğlu G; Bukan N; Aybar C
    Prostaglandins Leukot Essent Fatty Acids; 2005 Aug; 73(2):99-102. PubMed ID: 15961302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal metabolic acidosis: effect of chloride from normal saline flushes.
    Groh-Wargo S; Ciaccia A; Moore J
    JPEN J Parenter Enteral Nutr; 1988; 12(2):159-61. PubMed ID: 3129591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The solubility of calcium and phosphorus in neonatal total parenteral nutrition solutions.
    Dunham B; Marcuard S; Khazanie PG; Meade G; Craft T; Nichols K
    JPEN J Parenter Enteral Nutr; 1991; 15(6):608-11. PubMed ID: 1766049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of bioavailability of aluminium in neonatal parenteral nutrition solutions by prior complexation in the dosage form.
    Hayes P; Martin TP; Pybus J; Hunt J; Broadbent RS
    J Parenter Sci Technol; 1992; 46(5):169-75. PubMed ID: 1432456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and activity of intravenous immunoglobulin with neonatal dextrose and total parenteral nutrient solutions.
    Lindsay CA; Dang K; Adams JM; Ou CN; Baker CJ
    Ann Pharmacother; 1994 Sep; 28(9):1014-7. PubMed ID: 7803872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs.
    Staven V; Wang S; Grønlie I; Tho I
    Nutr J; 2016 Mar; 15():29. PubMed ID: 27000057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminosyn PF or trophamine: which provides more protection from cholestasis associated with total parenteral nutrition?
    Forchielli ML; Gura KM; Sandler R; Lo C
    J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):374-82. PubMed ID: 8583287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary dysfunction during total parenteral nutrition is caused by infusate, not the route of administration.
    Moss RL; Das JB; Ansari G; Raffensperger JG
    J Pediatr Surg; 1993 Mar; 28(3):391-6; discussion 396-7. PubMed ID: 8468653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of total parenteral nutrition using Vamin and Aminosyn as protein base in critically ill preterm infants.
    Sankaran K; Berscheid B; Verma V; Zakhary G; Tan L
    JPEN J Parenter Enteral Nutr; 1985; 9(4):439-42. PubMed ID: 3928917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.